{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P19526",
      "entity_text" : "HSC",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:Activin",
      "entity_text" : "activin",
      "entity_type" : "family"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The natural inhibitor of activin, follistatin, has been reported to attenuate CCl 4 -induced liver fibrosis by reducing HSC proliferation and activation, thus suggesting that activated activin signaling may contribute to liver fibrosis.",
  "reading_complete" : "2020-08-03T14:42:40Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:41:39Z",
  "trigger" : "attenuate",
  "evidence" : [ "activin, follistatin, has been reported to attenuate CCl 4 -induced liver fibrosis by reducing HSC" ],
  "pmc_id" : "5979935",
  "score" : 0
}